54gene Funding: $45M Raised, Series B (2021)

54gene is based in Lagos, Nigeria. It has raised $45M in total funding. Latest round: Series B.

54gene funding overview

54gene is based in Lagos, Nigeria. 54gene has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2021. The round record for 54gene runs through 2021; nothing later has been disclosed. Investors on record include Y Combinator, Adjuvant Capital, Cathay AfricInvest Fund. 3 distinct backers are named across the disclosed rounds.

54gene at a glance

Total raised
$45M
Latest round
Series B
Latest round date
September 2021
Headquarters
Lagos, Nigeria
Notable investors
Y Combinator, Adjuvant Capital, Cathay AfricInvest Fund

Frequently asked about 54gene funding

How much has 54gene raised?
54gene has raised $45M in total disclosed funding across the rounds on record.
Who has invested in 54gene?
Y Combinator, Adjuvant Capital, Cathay AfricInvest Fund are named among the investors backing 54gene.
What was the latest 54gene funding round?
The most recent disclosed round is a Series B, announced in September 2021.
Where is 54gene based?
54gene is based in Lagos, Nigeria.
When did 54gene last raise?
The last disclosed 54gene round closed in September 2021 at Series B.

54gene totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lagos below to benchmark round size and investor mix.

Companies related to 54gene (36)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026